Paper Details

  1. Home
  2. Paper Details

The Quality of Life and Medication Adherence in Patients with Multiple Sclerosis-Cross-Sectional Study.

Author: Chojdak-ŁukasiewiczJustyna, KołtuniukAleksandra, KrówczyńskaDorota, PytelAleksandra

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated the relationship between quality of life (QOL) and adherence to disease-modifying treatments (DMTs) in 344 MS patients. There were no statistically significant differences in QOL between adherent and non-adherent patients. However, adherence to treatment recommendations was significantly affected by QOL levels in the activities of daily living (ADL) and relationship with the healthcare system (RHCS) domains.
Paper Details　
Original Abstract of the Article :
Multiple sclerosis (MS) is a chronic, degenerative autoimmune inflammatory disease of the central nervous system. MS is characterized by a wide range of symptoms and unpredictable prognosis, which can severely affect patient quality of life (QOL). The treatment strategy includes acute relapse treatm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656792/

データ提供：米国国立医学図書館（NLM）

Multiple Sclerosis: Navigating the Desert of Quality of Life and Medication Adherence

Multiple sclerosis (MS) is a chronic, degenerative disease of the central nervous system that can significantly impact quality of life. This study examines the relationship between quality of life (QOL) and medication adherence in patients with relapsing-remitting MS. The researchers used a [cross-sectional study] to investigate the factors influencing medication adherence and their impact on QOL in MS patients. The study found that higher QOL levels in the domains of activities of daily living (ADL) and relationship with the healthcare system (RHCS) positively influenced medication adherence.

Navigating the MS Desert: A Focus on Quality of Life and Medication Adherence

This research underscores the importance of addressing both QOL and medication adherence in managing MS. The findings suggest that fostering a strong relationship with healthcare providers and promoting independence in daily living activities can significantly impact medication adherence.

Navigating the MS Desert: What You Need to Know

If you are living with MS, this research highlights the importance of maintaining a good relationship with your healthcare providers and focusing on your ability to manage daily living activities. These factors can play a significant role in your adherence to medications and, ultimately, in improving your overall QOL.

Dr.Camel's Conclusion

Multiple sclerosis, a challenging condition, can feel like a vast desert with many obstacles. This study emphasizes the importance of focusing on quality of life and medication adherence to navigate this journey. By fostering strong relationships with healthcare providers and prioritizing activities of daily living, MS patients can find ways to thrive in the desert of their condition.

Date :
  1. Date Completed 2022-11-14
  2. Date Revised 2023-01-17
Further Info :

Pubmed ID

36361427

DOI: Digital Object Identifier

PMC9656792

Related Literature

Article Analysis
・Effects of interferon beta-1b injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.